AccuPower® HPV Genotyping Kit

In vitro diagnostic kit for the detection of 27 HPV genotypes of HPV viral DNA in human cervical and vaginal swab samples

Ordering Information

The global incidence and death rates of cervical cancer rank the second and third highest respectively among women. It adds 4,000 ~ 5,000 new cases every year and the incidence rates in young women are increasing. The main cause of cervical cancer is Human papillomavirus (HPV) that infects cervix. HPV is known to be responsible for more than 90% of cervical cancer. According to the domestic study with 196 patients in cervical adenocarcinoma, HPV genotype 18 was responsible for the disease in 54.2% of the patients; HPV 16, in 44.1%; HPV 45, in 3.4%. HPV genotype 16 and 18 account for 60~70% of cervical cancer worldwide and are reported to be a risk factor to develop cervical intraepithelial neoplasia (CIN) with 30% probability.

AccuPower HPV Genotype detection format.

Intended Use

The AccuPower® HPV Genotyping Kit is an in vitro diagnostic kit designed for the simultaneous detection of 27 Human Papillomavirus genotypes in human cervical/vaginal swab samples through real-time polymerase chain reaction (PCR). The kit is configured for use with Exicycler™ 96.

Features and Benefits

 Convenience: Multiplex detection of 27 HPV genotypes.
 Enhanced Sensitivity &
UDG (Urasil DNA-glycosylase) and Bioneer’s proprietary HotStart technology accomplishes high sensitivity and specificity.
 Remarkable stability
   and reproducibility:
Vacuum-dried premix in each tube allows better stability than mastermix type, as well as provides reproducible results.
 High Quality: All diagnostic kits manufactured by Bioneer are under strict quality control guidelines.